Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Hormone therapy and different ovarian cancers: a national cohort study.

Mørch LS, Løkkegaard E, Andreasen AH, Kjaer SK, Lidegaard O.

Am J Epidemiol. 2012 Jun 15;175(12):1234-42. doi: 10.1093/aje/kwr446. Epub 2012 Apr 19.

PMID:
22517811
[PubMed - indexed for MEDLINE]
Free Article
2.

Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition.

Duell EJ, Travier N, Lujan-Barroso L, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello A, Tumino R, Sacerdote C, Rodriguez L, Sanchez-Cantalejo E, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Bueno-de-Mesquita HB, Jeurnink SM, Numans ME, Peeters PH, Lagiou P, Valanou E, Trichopoulou A, Kaaks R, Lukanova-McGregor A, Bergman MM, Boeing H, Manjer J, Lindkvist B, Stenling R, Hallmans G, Dahm CC, Overvad K, Olsen A, Tjonneland A, Bakken K, Lund E, Jenab M, McCormack V, Rinaldi S, Michaud D, Mouw T, Nesi G, Carneiro F, Riboli E, González CA.

Am J Epidemiol. 2010 Dec 15;172(12):1384-93. doi: 10.1093/aje/kwq321. Epub 2010 Nov 4.

PMID:
21051447
[PubMed - indexed for MEDLINE]
Free Article
3.

The endometrium--from estrogens alone to TSECs.

Pickar JH.

Climacteric. 2009 Dec;12(6):463-77. doi: 10.3109/13697130903042790. Review.

PMID:
19905899
[PubMed - indexed for MEDLINE]
4.

Estrous cycle modulates ovarian carcinoma growth.

Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW, Sood AK.

Clin Cancer Res. 2009 May 1;15(9):2971-8. doi: 10.1158/1078-0432.CCR-08-2525. Epub 2009 Apr 21.

PMID:
19383821
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Relationship between hormone therapy in women with ovarian malignancy and prognosis].

Li L, Pan ZM, Chen XQ, Gao K, Zhang W, Luo Y, Yao ZQ, Liang XQ, Huang W, Yao DS.

Zhonghua Fu Chan Ke Za Zhi. 2008 Nov;43(11):843-8. Chinese.

PMID:
19087569
[PubMed - indexed for MEDLINE]
6.

Cancer issues.

Marsden J, Sturdee D.

Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):87-107. doi: 10.1016/j.bpobgyn.2008.10.005. Epub 2008 Nov 25.

PMID:
19036643
[PubMed - indexed for MEDLINE]
7.

Association of ovarian and uterine cancers with postmenopausal hormonal treatments.

Neves-E-Castro M.

Clin Obstet Gynecol. 2008 Sep;51(3):607-17. doi: 10.1097/GRF.0b013e318180b988. Review.

PMID:
18677154
[PubMed - indexed for MEDLINE]
8.

[How to reduce the incidence of breast cancer].

Rochefort H, Rouëssé J; Groupe de Travail de la Commission III (Cancérologie).

Bull Acad Natl Med. 2008 Jan;192(1):161-79. Review. French.

PMID:
18663989
[PubMed - indexed for MEDLINE]
9.

Hormonal therapies and gynaecological cancers.

Garrett A, Quinn MA.

Best Pract Res Clin Obstet Gynaecol. 2008 Apr;22(2):407-21. Epub 2007 Sep 19. Review.

PMID:
17884734
[PubMed - indexed for MEDLINE]
10.

Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy.

Tanaka S, Kawamura T, Nakamura N, Teramoto K, Arii S.

Dig Dis Sci. 2007 May;52(5):1326-8. Epub 2007 Mar 20.

PMID:
17372823
[PubMed - indexed for MEDLINE]
11.

[Progesterone and breast cancer].

Mansueto G, Mistretta V, Angeletti F, Trento LK, Angelozzi D, Bracaglia M, Pagliarella MR, Di Muccio L.

Recenti Prog Med. 2006 Jul-Aug;97(7-8):376-80. Review. Italian.

PMID:
16913172
[PubMed - indexed for MEDLINE]
12.

Endogenous estrogen status, but not genistein supplementation, modulates 7,12-dimethylbenz[a]anthracene-induced mutation in the liver cII gene of transgenic big blue rats.

Chen T, Hutts RC, Mei N, Liu X, Bishop ME, Shelton S, Manjanatha MG, Aidoo A.

Environ Mol Mutagen. 2005 Jun;45(5):409-18.

PMID:
15662719
[PubMed - indexed for MEDLINE]
13.

Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats.

Yuzurihara M, Ikarashi Y, Noguchi M, Kase Y, Takeda S, Aburada M.

Urology. 2004 Nov;64(5):1042-7.

PMID:
15533515
[PubMed - indexed for MEDLINE]
14.

Estrogen, progesterone and epithelial ovarian cancer.

Ho SM.

Reprod Biol Endocrinol. 2003 Oct 7;1:73. Review.

PMID:
14577831
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR.

Int J Cancer. 2003 Nov 20;107(4):647-51.

PMID:
14520705
[PubMed - indexed for MEDLINE]
16.

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

Verschraegen CF, Westphalen S, Hu W, Loyer E, Kudelka A, Völker P, Kavanagh J, Steger M, Schulz KD, Emons G.

Gynecol Oncol. 2003 Sep;90(3):552-9.

PMID:
13678723
[PubMed - indexed for MEDLINE]
17.

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

Sit AS, Modugno F, Weissfeld JL, Berga SL, Ness RB.

Gynecol Oncol. 2002 Aug;86(2):118-23.

PMID:
12144815
[PubMed - indexed for MEDLINE]
18.

[Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].

Hubina E, Kovács L, Szabolcs I, Rimanóczy E, Czirják S, Góth M.

Orv Hetil. 2002 Mar 24;143(12):601-5. Hungarian.

PMID:
11963397
[PubMed - indexed for MEDLINE]
19.

Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives.

Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P.

Ann N Y Acad Sci. 2001 Sep;943:296-315. Review.

PMID:
11594550
[PubMed - indexed for MEDLINE]
20.

Hormonal activity of transposed ovaries in young women treated for cervical cancer.

Olejek A, Wala D, Chimiczewski P, Rzempoluch J.

Gynecol Endocrinol. 2001 Feb;15(1):5-13.

PMID:
11293925
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk